About Unidrug
Unidrug is a Healthcare company based in Indore (India). API development, manufacturing, and marketing with global exports from India. It operates on a B2B model. The company has 33 employees. Its Indian entity Unidrug Innovative Pharma Technologies Limited reported revenue of ₹44.46 Cr. Unidrug offers products and services including APIs and Intermediates. Its focus areas include Pharmaceuticals, API Manufacturing and Chemical Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Unidrug, based in Indore, India, is an API manufacturing company that has specialized in developing, manufacturing, and marketing active pharmaceutical ingredients and intermediates for over 30 years. It operates state-of-the-art, GMP-certified facilities and exports to 14 countries, prioritizing product quality, safety, and sustainability while maintaining strict delivery schedules.
- Headquarters Indore, India
- Employees 33
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website unidrugindia.com
- Social LinkedIn Facebook
- Legal Name Unidrug Innovative Pharma Technologies Limited
- Date of Incorporation 13 Mar, 1987
- Jurisdiction Indore, Madhya Pradesh, India
- Annual Revenue₹44.46 Cr
FY 2025 · +28% YoY
- Net Profit₹2.09 Cr
FY 2025 · 5% margin
- EBITDA₹4.39 Cr
FY 2025 · 10% margin
- Employee Count33
Associated legal entities of Unidrug
Unidrug operates through Unidrug Innovative Pharma Technologies Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Unidrug Innovative Pharma Technologies Limited CIN U85120MP1987PLC003875 | Active | 13 Mar 1987 | Indore, Madhya Pradesh | ₹44.5 Cr | 33 | 5 | View details |
Products & Services of Unidrug
Unidrug offers a comprehensive portfolio of products and services, including APIs and Intermediates.
Development and manufacturing of active pharmaceutical ingredients
Manufacturing of chemical intermediates for pharmaceutical use
Board of directors of Unidrug Innovative Pharma Technologies Limited (Unidrug)
Unidrug Innovative Pharma Technologies Limited is the primary company behind Unidrug. The board of Unidrug Innovative Pharma Technologies Limited currently have 4 directors; the longest-serving is Jainesh Jain, appointed in 1995. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jainesh Jain DIN 02355170 | Managing Director | 20 Aug 1995 | 31 yrs 2 mo | Unidrug Innovative Pharma Technologies Limited |
| Varsha Jain DIN 00255907 | Director | 05 Oct 1995 | 31 yrs | Unidrug Innovative Pharma Technologies Limited |
| Gajanand Agrawal DIN 08215163 | Director | 20 Sep 2018 | 8 yrs 1 mo | Unidrug Innovative Pharma Technologies Limited |
| Bharat Jain DIN 00035708 | Director | 20 Sep 2018 | 8 yrs 1 mo | Unidrug Innovative Pharma Technologies Limited |
People of Unidrug
2 people are tracked at Unidrug (2 in leadership); the tracked headcount is 33.
| Name | Role | Group |
|---|---|---|
| Co-Owner, Managing Director | Leadership | |
Rachana Lunawat Jain | Co-Owner | Leadership |
Complete people profiles for Unidrug
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Unidrug
Figures of Unidrug Innovative Pharma Technologies Limited, the primary company behind Unidrug, for FY 2025. Revenue was ₹44.46 Cr (+28% year on year). Net profit was ₹2.09 Cr (5% margin). EBITDA was ₹4.39 Cr (10% margin). Revenue has grown at a compounded annual rate of 0% over three years and +5% over five years.
- ₹44.46 CrRevenue · FY 2025 · +28% YoY
- ₹2.09 CrNet profit · 5% margin
- ₹4.39 CrEBITDA · 10% margin
- ₹9.58 CrPaid-up capital
- 33Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Unidrug Innovative Pharma Technologies Limited are on its company page.
Detailed financial statements for Unidrug
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Unidrug
Unidrug has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Unidrug
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Unidrug
Unidrug is headquartered in Indore, India. It is registered at Indore, Madhya Pradesh, India.
Unidrug has 33 employees.
The primary company behind Unidrug, Unidrug Innovative Pharma Technologies Limited, reported revenue of ₹44.46 Cr for FY 2025, up 28% year on year.
Unidrug, based in Indore, India, is an API manufacturing company that has specialized in developing, manufacturing, and marketing active pharmaceutical ingredients and intermediates for over 30 years. It operates state-of-the-art, GMP-certified facilities and exports to 14 countries, prioritizing product quality, safety, and sustainability while maintaining strict delivery schedules.
Unidrug's top competitors include Laurus Labs, Symbiotec and SeQuent.
Unidrug offers APIs and Intermediates.
Unidrug operates through Unidrug Innovative Pharma Technologies Limited.
The legal entities of Unidrug currently have 5 directors, including Jainesh Jain, Gajanand Agrawal, Bharat Jain and others.